Research and Development

Research and Development

Patent portfolio

Biomarker portfolio

  1. “Prognostic and Diagnostic Glycan-based Biomarkers of Brain Damage” Granted European Patent No. 3283880.
  2. “Non-invasive brain injury diagnostic device” U.S. Patent application No. 62/461,277, WO2018154401; National applications pending 
  3. ”Device and method for detecting of brain injury in a subject” Filed as FI 20196004

  4. ”A method for determining a lectin binding glycan indicative to traumatic brain injury” US application 16/840,931.




NCE portfolio

  1. ”Multivalent compounds for use in the treatment and prevention of brain damage" Granted Finnish patent FI 127 024; Granted US patent US 9,975,846; Israeli patent (final stage)
  2. ”Compositions, and compositions for use in preventing or treating of brain damage and neurodegenerative diseases” Filed as FI 20195715